D'ANDREA, MARCO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 5.278
AS - Asia 1.407
EU - Europa 1.385
AF - Africa 130
SA - Sud America 63
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.311
Nazione #
US - Stati Uniti d'America 5.201
IT - Italia 479
SG - Singapore 374
IE - Irlanda 304
CN - Cina 176
SA - Arabia Saudita 143
GB - Regno Unito 133
DE - Germania 122
IN - India 98
IR - Iran 90
JP - Giappone 86
PK - Pakistan 74
KR - Corea 71
HK - Hong Kong 62
RU - Federazione Russa 53
CA - Canada 52
FI - Finlandia 49
AU - Australia 40
TR - Turchia 36
NG - Nigeria 34
IQ - Iraq 32
BR - Brasile 30
CZ - Repubblica Ceca 30
JO - Giordania 30
PH - Filippine 30
FR - Francia 26
MY - Malesia 26
EG - Egitto 24
MX - Messico 24
ES - Italia 22
SE - Svezia 22
TH - Thailandia 21
CH - Svizzera 19
PL - Polonia 18
ZA - Sudafrica 18
BE - Belgio 16
NL - Olanda 15
ET - Etiopia 14
GH - Ghana 14
VN - Vietnam 14
UA - Ucraina 13
AT - Austria 12
ID - Indonesia 12
TW - Taiwan 11
RO - Romania 10
CO - Colombia 9
DK - Danimarca 9
CL - Cile 8
IL - Israele 8
DZ - Algeria 7
GR - Grecia 7
NO - Norvegia 7
TN - Tunisia 7
EC - Ecuador 6
HU - Ungheria 5
NZ - Nuova Zelanda 5
AR - Argentina 4
ER - Eritrea 4
LY - Libia 4
PE - Perù 4
PT - Portogallo 4
RS - Serbia 4
MO - Macao, regione amministrativa speciale della Cina 3
MW - Malawi 3
BD - Bangladesh 2
CY - Cipro 2
EE - Estonia 2
EU - Europa 2
LT - Lituania 2
NP - Nepal 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CU - Cuba 1
GE - Georgia 1
KE - Kenya 1
KZ - Kazakistan 1
QA - Qatar 1
UY - Uruguay 1
VE - Venezuela 1
YE - Yemen 1
Totale 8.311
Città #
Wilmington 915
Houston 753
Fairfield 491
Chandler 471
Woodbridge 379
Ashburn 334
Singapore 311
Dublin 271
Medford 202
Seattle 184
Cambridge 165
Jeddah 131
Ann Arbor 123
Beijing 106
Rome 98
Lawrence 92
New York 91
Santa Clara 54
San Diego 45
Helsinki 43
Hamburg 40
Philadelphia 35
Redwood City 34
Seoul 32
Amman 29
Central 28
Minneapolis 26
Prague 25
London 24
Chuo 22
Menlo Park 21
Moscow 21
Milan 20
Los Angeles 19
Tokyo 19
Toronto 18
Des Moines 14
Falls Church 14
Nanjing 14
Bologna 13
Cairo 13
Florence 13
Lahore 13
Delhi 12
Melbourne 12
Munich 12
Norwalk 12
Osimo 12
Quezon City 12
Birmingham 11
Calgary 11
Hanoi 11
Hong Kong 11
Jena 11
Kirkuk 11
Naples 11
New Delhi 11
Southampton 11
Turin 11
Washington 11
Istanbul 10
Seodaemun-gu 10
Tehran 10
Isfahan 9
Kochi 9
Lagos 9
Petaling Jaya 9
Rawalpindi 9
Manchester 8
Manhattan 8
Montreal 8
Mumbai 8
Oceanside 8
Accra 7
Bari 7
Brussels 7
Chennai 7
Chiang Mai 7
Durban 7
Frankfurt am Main 7
Genoa 7
Guangzhou 7
Islamabad 7
Kilburn 7
Mountain View 7
Sydney 7
São Paulo 7
Vienna 7
Woodland 7
Zaragoza 7
Adelaide 6
Bangkok 6
Berlin 6
Boardman 6
Curitiba 6
Engelhard 6
Kumasi 6
Northridge 6
Paris 6
Port Harcourt 6
Totale 6.253
Nome #
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 545
Fighting multi-drug resistant Klebsiella pneumoniae by using lytic phages 430
φbO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage 421
Exploiting phages–bacteria co-evolution to overcome phage resistance and to ease the selection of new phage particles 360
Draft genome sequence of the agarase-producing Sphingomonas sp. MCT13 348
Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101 213
MCT13: a newly discovered agarase-producing Sphingomonas sp. Isolated from freshwaters 206
Isolation and characterization of lytic bacteriophages targeting major multi-drug resistant high-risk clones of carbapenemase-producing Klebsiella pneumoniae 192
Isolation and characterisation of vB_Kpn_F48, a novel bacteriophage for Klebsiella pneumoniae 190
The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance 187
Chromosomal Integration of blaKPC-2 in Proteus mirabilis Clinical Isolates 185
First report of multi-drug resistant, VEB-6 producing Proteus mirabilis isolates from Italy 184
Sphingomonas turrisvirgatae a new agar-degrading Sphingomonas species 169
Preclinical study of a combined host- and pathogen directed approach based on bioactive liposomes and bacteriophages against Mycobacterium abscessus infection 169
Sphingomonas turrisvirgatae sp. nov., an agar-degrading species isolated from freshwater. 151
The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains 150
Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: Increasing diversity with predominance of the ST512 clade II sublineage 142
Genetic linkage of optrA and cfr, integrated into an unconventional circularisable structure, in Enterococcus faecium 141
Italian nationwide survey on pseudomonas aeruginosa from invasive infections: Activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers 136
Tn6349: a novel cfr- and poxtA-carrying transposon of enterococcal origin in a linezolid-resistant MRSA 134
SELECTION AND CHARACTERISATION OF PHAGES ABLE TO DEGRADE BIOFILM PRODUCED BY CLINICAL ISOLATES OF E. FAECALIS 114
Characterization of vb_stus_mmda13, a newly discovered bacteriophage infecting the agar-degrading species sphingomonas turrisvirgatae 108
Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms 99
DNABII targeting antibodies as vaccines against biofilm diseases 87
CTX-M-type β-lactamases: A successful story of antibiotic resistance 86
Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin 85
The changing epidemiology of carbapenemase-producing Klebsiella pneumoniae in Italy: toward polyclonal evolution with emergence of high-risk lineages 83
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii 81
Characterization of a multiresistance plasmid carrying the optra and Cfr resistance genes from an enterococcus faecium clinical isolate 81
Determination of the capsular polysaccharide structure of the Klebsiella pneumoniae ST512 representative strain KPB-1 and assignments of the glycosyltransferases functions 81
Characterization of bacteriophages with lytic activity for major clones of KPC-producing Klebsiella pneumoniae. 75
Evidence of another anthropic impact on iguana delicatissima from the lesser Antilles: the presence of antibiotic resistant enterobacteria 75
Cross-infection of solid organ transplant recipients by a multidrug-resistant Klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor 71
Characterization of Tn6349, a novel mosaic transposon carrying poxtA, cfr and other resistance determinants, inserted in the chromosome of an ST5-MRSA-II strain of clinical origin 70
Abundance of Colistin-Resistant, OXA-23- and ArmA-Producing Acinetobacter baumannii Belonging to International Clone 2 in Greece 68
Complete genome sequence of the first KPC-type carbapenemase-positive Proteus mirabilis strain from a bloodstream infection 65
Characterization of a novel putative Xer-dependent integrative mobile element carrying the blaNMC-A carbapenemase gene, inserted into the chromosome of members of the Enterobacter cloacae complex 65
CMY-16, a novel acquired AmpC-type β-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy 64
Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response 63
Structure of the capsular polysaccharide of the KPC-2-producing Klebsiella pneumoniae strain KK207-2 and assignment of the glycosyltransferases functions 62
Lytic bacteriophages against KPC-KP and their efficacy in a preclinical model. 61
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy 59
Phage Resistance Is Associated with Decreased Virulence in KPC-Producing Klebsiella pneumoniae of the Clonal Group 258 Clade II Lineage 59
Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase 58
Colistin resistance caused by inactivation of the MgrB regulator is not associated with decreased virulence of sequence type 258 KPC carbapenemase-producing Klebsiella pneumoniae 58
Bioactive liposomes for the control of Mycobacterium abscessus infection. 56
Molecular and physiological characterization of a new lytic bacteriophage against KPC-positive Klebsiella pneumoniae. 54
Phage-resistance mechanism in KPC-producing Klebsiella pneumoniae of the clonal group 258 clade II lineage 54
Genomic Epidemiology of Carbapenem- and Colistin-Resistant Klebsiella pneumoniae Isolates From Serbia: Predominance of ST101 Strains Carrying a Novel OXA-48 Plasmid 53
First case of bacteremic liver abscess caused by an ST260-related (ST1861), hypervirulent Klebsiella pneumoniae 52
Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: Report on the first Italian cases 52
Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages 52
Combined host- and pathogen-directed therapy for the control of mycobacterium abscessus infection 52
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 52
Acquired AmpC type beta-lactamases: An emerging problem in Italian long-term care and rehabilitation facilities 51
The spread of CTX-M-type extended-spectrum β-lactamases 50
Plasmid-mediated or chromosomally mediated colistin resistance in Klebsiella pneumoniae? 50
Draft genome sequence of the first hypermucoviscous Klebsiella quasipneumoniae subsp. quasipneumoniae isolate from a bloodstream infection 50
Mining microbial metatranscriptomes for expression of antibiotic resistance genes under natural conditions 50
Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type β-lactamase: epidemiology and clinical management 49
Isolation of Klebsiella pneumoniae strains with altered susceptibility to carbapenems not carbapenemase mediated 49
Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe 49
MgrB inactivation is a common mechanism of colistin resistance in KPC-producing klebsiella pneumoniae of clinical origin 47
Management of meningitis caused by multi drug-resistant Acinetobacter baumannii: Clinical, microbiological and pharmacokinetic results in a patient treated with colistin methanesulfonate 47
Effects of selective digestive decontamination (SDD) on the gut resistome 47
Linezolid-resistant cfr-positive MRSA, Italy 46
In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator 46
Application of bacteriophages for human health: an old approach against contemporary “bad bugs” 46
pHTβ-promoted mobilization of non-conjugative resistance plasmids from Enterococcus faecium to Enterococcus faecalis 45
Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review 45
Diversity of capsular polysaccharide gene clusters in Kpc-producing Klebsiella pneumoniae clinical isolates of sequence type 258 involved in the italian epidemic 44
Fighting MDR-Klebsiella pneumoniae infections by a combined host- and pathogen-directed therapeutic approach 43
DNA microarray for detection of macrolide resistance genes 43
The seagrass holobiont: What we know and what we still need to disclose for its possible use as an ecological indicator 42
Draft genome sequence of Proteus mirabilis NO-051/ 03, representative of a multidrug-resistant clone spreading in Europe and expressing the CMY-16 AmpC-type β-lactamase 41
Evaluation of the KPC K-SeT™ immunochromatographic assay for the rapid detection of KPC carbapenemase producers from positive blood cultures 39
Large oligoclonal outbreak due to klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit 39
In vivo evolution to Colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment 39
Differences in Inflammatory Response Induced by Two Representatives of Clades of the Pandemic ST258 Klebsiella pneumoniae Clonal Lineage Producing KPC-Type Carbapenemases 39
A dirty job: dishwasher wastewater reuse and upcycle through an ad hoc engineered microbial consortium 36
Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in Northern Italy 36
Newborn bacteraemia caused by an Aeromonas caviae producing the VIM-1 and SHV-12 β-lactamases, encoded by a transferable plasmid 35
Genomic epidemiology of carbapenem- and colistin-resistant Acinetobacter baumannii from Greece 35
Differential Th17 response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae clonal lineages producing KPC-type carbapenemase 35
Microbial consortia in wastewater treatment and up-cycling. 33
OXA-372, a novel carbapenem-hydrolysing class D β-lactamase from a Citrobacter freundii isolated from a hospital wastewater plant 30
Nasopharingeal bacterial and fungal colonization in HIV-positive versus HIV-negative adults 29
Galleria mellonella for assessing the efficacy of monoclonal antibodies against Staphylococcus aureus 27
Primo isolamento della carbapenemasi IMI-2 plasmide mediata in E. cloacae complex in Italia. 27
Phage-resistance in Klebsiella pneumoniae clinical isolates may correlate to augmented clearance by phagocytes 26
The interplay of diagnostic and antimicrobial stewardship for the management of septic patients: The Tuscan model 26
Carbapenem-resistant Klebsiella pneumoniae: the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge 25
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane-tazobactam and comparators, and molecular epidemiology of carbapenemase producers. 25
Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases 24
Differential inflammatory response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae. 24
NDM-1 encoding plasmids in multiple Enterobacteriaceae from a pediatric patient. 23
First detection of linezolid-resistant optrA-positive clinical isolate of Enterococcus faecalis in Italy. 23
Evaluation of Chromatic™ OXA-48 medium for direct detection of OXA-48 producing Enterobacteriaceae from rectal swabs. 23
Differential features of the two clades of ST258 KPC-producing Klebsiella pneumoniae caused by different expression of the Mrk fimbrial system. 21
Long-lasting persistence of NDM-1-encoding plasmids in multiple enterobacterial species in a pediatric patient. 20
Totale 8.727
Categoria #
all - tutte 34.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.343 0 0 0 17 23 25 261 199 304 225 85 204
2020/20211.881 114 196 176 273 125 208 215 207 57 168 51 91
2021/20221.134 54 114 44 10 62 71 77 145 74 63 96 324
2022/20231.332 141 118 97 140 85 330 123 66 113 18 55 46
2023/20241.802 89 35 49 249 190 392 221 184 91 93 98 111
2024/2025907 169 436 295 7 0 0 0 0 0 0 0 0
Totale 8.771